Pliant Therapeutics, Inc. (PLRX) Misses Q2 EPS by 7c

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q2 EPS of ($0.92), $0.07 worse than the analyst estimate of ($0.85).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• JPMorgan Starts TIME dotCom Berhad (TDC:MK) at Overweight
• Select Medical stockholders approve buyout by insider-led consortium
• Uranium Royalty Corp. sets shareholder vote on $1.14B Sweetwater deal